The sharp rise in out-of-pocket healthcare spending

screwed1The sharp rise in out-of-pocket healthcare spending

https://drugstorenewsce.com/content/sharp-rise-out-pocket-healthcare-spending

ANN ARBOR, Mich. — Even if you have what you might think of as good health insurance, your next hospital stay could cost you more than $1,000 out of your own pocket.

And that amount has gone up sharply in recent years — a rise of more than 37% just for straightforward hospital stays for common conditions.

Those striking statistics come from the first published analysis of actual out-of-pocket spending by people with private health insurance, most of it provided by employers. It’s appearing today in the JAMA Internal Medicine, and being presented at the AcademyHealth Annual Research Meeting in Boston.

To see the rise in costs paid by privately insured hospital patients, researchers at the University of Michigan’s Institute for Healthcare Policy and Innovation looked at data from more than 50 million Americans in a four-year period.

All of them had insurance plans offered by the four major companies that pool their data via the Health Care Cost Institute, of which IHPI is an academic partner.

The biggest change in out-of-pocket spending came from two types of insurance plan charges: one that patients are familiar with, and the other that is not so familiar.

Deductibles — the amount that patients pay for their care before their insurance kicks in — rose by 86%. Co-insurance — a percentage of the cost of the hospital stay that insurance plans often expect patients to pay, but patients may not even realize they will owe — rose 33%.

“These results open up the ‘black box’ of health care, and show all the costs of hospitalization that are billed to people with private insurance. For many, these may appear to be ‘hidden costs’ that they didn’t realize they would owe,” says first author Emily Adrion, PhD, MSc, a U-M research fellow with the Center for Healthcare Outcomes and Policy. “It shows that even people with the most comprehensive insurance are paying thousands of dollars, at a time when they need hospital care and may not have time to shop around.”

She and her colleagues, including senior author Brahmajee Nallamothu, MD, MPH, note that the growth in out-of-pocket costs was 6.5% a year, compared to a 5.1% growth in health insurance premiums, and a 2.9% growth in overall healthcare spending.

The study looked at costs billed to people between the ages of 18 and 64, from 2009 to 2013. In addition to a broad-based analysis, the researchers took a closer look at those who had heart attacks, pneumonia, appendicitis, heart bypasses, total knee replacement or spinal fusion procedures, and women who gave birth.

It’s different from other studies that have estimated out-of-pocket spending based on the design of insurance plans.

The percentage of patients who were charged deductibles and co-insurance rose by more than five percentage points during the study period.

Co-payments, which are different from co-insurance and are a kind of “entry fee” to a hospitalization, actually fell during this time. But this was due to the fact that fewer insurance plans charged a co-pay for a hospital stay in 2013 than had charged one in 2009 — not to an actual drop in the dollar amount of the co-pays charged to patients who owed one.

The study also reveals sharp differences in out-of-pocket costs for people who chose “consumer-directed” health plans offered by their employers — which often take the smallest bite out of each paycheck — and for people who bought individual private plans during the study period.

For those with consumer-directed plans, the total they’d owe after a straightforward hospital stay topped $1,200 on average. Their employer may have also offered them a way to save pre-tax dollars in a special account to help pay for that, but the study data don’t show that information.

For those with individual private plans, the bite was even harsher: $1,800 on average. Adrion notes that to qualify for an individual private plan during the study period, patients would have to have met standards for good health. A provision mandating that plans cover all adults regardless of pre-existing conditions didn’t take effect until 2014.

“These results show the importance of reading the fine print when you choose a health insurance plan, and being prepared to spend more out of your own pocket after a hospitalization than you might have expected,” says Nallamothu, a professor of internal medicine at U-M and IHPI member.

Patients can also make sure they understand which hospitals and doctors are “in network” for their plan, which might mean lower co-insurance costs. And, for people who can’t pay their entire bill at once, or at all, it means talking to the hospital about a payment plan or even a write-off of some costs under their charity care policy.

The study period didn’t include private individual and family plans bought on the exchanges set up under the Affordable Care Act. Those plans began covering people in January 2014 and are open to anyone regardless of their health status. The study period did include the first years when the ACA mandated that adults up to age 26 could remain on their parents’ private health plans.

Recent estimates by the Kaiser Family Foundation suggest that the trend seen in these data has continued. According to a recent KFF report, 81% of people who get insurance through an employer have an annual deductible of about $1,300, and more than two-thirds of them also have co-insurance as part of their coverage. An even greater percentage of people who bought “silver” plans on an ACA exchange also have co-insurance provisions in their plans.

But plans bought on the ACA exchanges (including healthcare.gov) come with a federal cap on out-of-pocket spending of $6,800. Plans provided by employers, or bought individually outside the exchanges, don’t have such a cap. Adrion and her colleagues plan to study future HCCI data to look at spending trends.

The personal beliefs of pharmacists cannot outweigh their professional duty — or the law

Supreme Court right to not interfere with Wash. state’s pharmacy contraceptive rules

http://www.seattletimes.com/opinion/editorials/supreme-court-right-to-not-interfere-with-wash-states-pharmacy-contraceptive-rules/

I wonder if Judge Susan Graber‘s opinionSpeed is particularly important considering the time-sensitive nature of emergency contraception and of

many other medications…

The personal beliefs of pharmacists cannot outweigh their professional duty — or the law.”

could apply to medications that are used for subjective diseases (pain, anxiety, depression, ADD/ADHD, mental health) that the pt should not be subjected cannot send the woman to another pharmacy miles awaywhich seems to describe the “Pharmacy crawl “

Does this open a “can of worms” for those Pharmacists who believe that they can reject filling a otherwise legal Rx … for any reason ?

The U.S. Supreme Court was right not to interfere with Washington’s rules regarding a woman’s access to emergency contraception at the pharmacy.

 It took nine years, but the abortion proxy war at the pharmacy counter is finally over.

The U.S. Supreme Court last week declined to consider Washington’s 2007 rules, essentially ensuring women’s access to emergency contraception.

 In taking a pass, the Supreme Court upheld the 9th U.S. Circuit Court of Appeals ruling last year, which found that Washington’s rules struck just the right balance between a pharmacist’s professional duty to fill a lawful prescription and his or her religious-based objection to emergency contraception, such as Plan B, because it can stop conception or terminate a fertilized egg.
 The pharmacy board’s rules were thoughtful back in 2007, when they were acting on reports that some pharmacists were refusing to dispense prescriptions that followed a decision made by a woman and her doctor. And they are particularly good nearly a decade later, when access to a full range of reproductive medicine continues to be under attack.
[Pro/con: Should pharmacists have religious freedom in America?]

In recent weeks, a state judge correctly ruled that public hospital districts must follow state law and provide abortions themselves — and not outsource the duty to Planned Parenthood — if they provide maternity care. And the U.S. Supreme Court turned back Texas’ stealth attempt to shut down abortion clinics with undue medical regulations.

In the pharmacy case, the state rules say a pharmacist can simply hand an objectionable prescription to another non-objecting pharmacist on-site, if one is available, but cannot send the woman to another pharmacy miles away.

Speed is particularly important considering the time-sensitive nature of emergency contraception and of many other medications,” federal appellate Judge Susan Graber wrote in the 9th Circuit Court of Appeals ruling last year. She also noted that the pass-the-prescription game subjected women to shame for seeking a lawful medicine.

The personal beliefs of pharmacists cannot outweigh their professional duty — or the law.

 

Forgotten news: Bill Clinton was DISBARRED for perjury

Legalized MMJ: Because there’s too much money to be made

DEA Source Confirms that Schedule II Marijuana is in the Works.

http://www.smobserved.com/story/2016/07/04/news/dea-source-confirms-that-schedule-ii-marijuana-is-in-the-works/1562.html

“Let me tell you how the big pharma industry works,” said the DEA lawyer, picking up a glass of chardonnay and swirling it around. We were having lunch at Shutters on the Beach, and the wine, which I would pay for, cost $150 a glass. But he had promised to answer some questions from readers of my controversial article entitled “US Gov’t Will Legalize Marijuana August 1.” http://www.smobserved.com/story/2016/06/28/news/us-govt-will-legalize-marijuana-on-august-1/1484.html

“I’ll tell you how this industry works. The big pharma people take the DEA people to dinner to discuss the legalization of Marijuana, how it’s going to really work. They say:

‘Listen, you and I both know that cannabis is much less dangerous, much less addictive than a lot of other schedule II stuff that we already sell, such as Oxycontin. Why don’t we just go ahead and sell a few products, THC extract, TBD oil, so we can all make some money. Instead of all these small time weed clinic guys with their pot clinics banking the cash, let us bank it. The side effects are probably not nearly as bad as other drugs like Oxycontin. It’s not the result of chemists committing unnatural acts with molecules. And a few years from now, when you need a job, you can come work for me.’ I’m sure that’s how it works.”

He’s a tall man, a tall blue eyed DEA lawyer. I’ll call him “Deep Throat.” He met with me on condition I not say anything that might compromise his identity, because he was not authorized to speak to the press. I read him questions from readers, and he answered them over filet mignon and wine.

1. Does this mean insurance companies – including ones with Medicare or Medicaid patients will have access to prescriptions, and having the cost covered by their insurance company at the pharmacy? Like any other drug?

Yes. Under State law, coverage exclusions would run into federal issues. It’s always a plan by plan question, but as a default I would say it would be covered. Why not? As long as prescription medications are covered, under ERISA or other Federal law.

2. Stan, the DEA actually stated in a memo to lawmakers a couple of months back that they would be deciding on marijuana scheduling by the end of June. The Denver Post story talking about July 1 isn’t stating anything new. But THIS story certainly is! Congratulations! I’ve been sharing it all over.

Yes, and did you notice that the June deadline came and went? Just as a matter of logic, the statement that nothing is new is wrong. The decision has already been made, folks. Schedule II marijuana is in the works. We’re just working out the details before we go public with it.

3. This will destroy the existing industry. How about all the people that spent their life savings to get licensed and open up a dispensary? How about all the manufacturers of oils and edibles that won’t be able to conform to FDA regulations? Clinical trials are lengthy and expensive. CVS will be responsible for selecting product for consumers. The black market will explode again.

[Sighs, looks at his salad again]. Yeah, I keep hearing that. Yes, it might destroy the existing industry. Maybe it should. Because the public would be better served by pharmacists. Of course they would be.

The DEA might never squeeze them for it (if they did sell weed), but the Pharmacists can’t fill a marijuana clinic recommendation, or they’re in violation of their licenses. And it’s illogical, they’re exactly the people who should be in. The people that we at the DEA regulate, are exactly the people who should enjoy the legal right to sell marijuana products. That’s fair, and also in the public interest.

If all this state regulation is superceded by General regulation, but I don’t see why that’s a bad thing. Don’t you trust CVS more? This industry as it is now is operating in a grey area. It would be better for patients and society if it were not a public health or safety issue.

4. The problem is allowing the whole MJ plant to be legal. What the layman does NOT understand is there are specific parts of the plant that are harmful, and others that do have very solid evidence-based research to support it. THC is mood altering, and harmful to any human < 25yrs old. Many peer reviewed studies linking THC to schizophrenia, reduced motivation, reduced education, etc. Cannabidiol however is incredible. Proven research for its benefits.

[throws down his fork] Yes yes yes, and moving marijuana to schedule II is all about allowing people to do clinical research. I’m all in favor of that, as are my colleagues at the DEA.

Personally though, I don’t see how you can just wave a magic wand and say all this weed stuff is now Schedule II. This will have to go thru the same trials as anything else on Schedule 4. We parse through what is or is not a drug on the plant.

And that opens the possibility that what is more controversial could survive. But you’re open to some real possibility that some stuff will not survive for having to go thru FDA approval, with FDA saying what they like and don’t like. Exhaustive scientific studies will be performed, including human studies. And again, this is something others would be able to pay for. Describing a side effect would remove credibility from those people on the margins

You couldn’t just say Hemp is good, you could say it’s through the FDA wringer. If parts are good and parts aren’t, we’re gonna find out. And that’s something your local green clinic operator will never do for you, would he?

5. It’s about time… We need to remove marijuana from the DEA drug schedule list. Look at alcohol, it has no more currently accepted medical use than marijuana and has a high potential for abuse. We need to stop destroying lives and regulate marijuana like alcohol. If the legalization of marijuana stops one alcohol overdose, what’s a life worth?

I hear this comparison a lot. It’s fair to raise the argument that alcohol is destructive when abused. In a way that pot isn’t, though marijuana does some stuff alcohol doesn’t. Our current alcohol regime is a result of an historic compromise over decades. The comparison fails because of the different history.

There’s a huge problem with addiction in the US, you can talk about opiods, alcohol, video games (laughs). There’s a big problem with addiction that America doesn’t yet recognize or do anything about.

Does the danger of addiction with marijuana outweigh its therapeutic benefits? Maybe there’s an under investment in addiction in the US, the AMA has resisted spending more money on it. That’s another reason why a lot of this argument has to be looked at with a jaundiced eye, because of all the money being spent on it.

They’re not trained clinicians. How would they know from records? They have no organized system of record keeping. It’s like saying gangsters should still have control over alcohol. It doesn’t mean the dispensaries are evil people, it’s just a lack of record keeping that would give them exp.

An essential element in medical record keeping is the standard of care. It’s frankly a political compromise, and it’s been set up over time.

There may be individual weed clinic people who are awesome at it, but as a group, the pharmacists have it beat. Because they’re heavily regulated and licensed people.

We are living through a time as momentous as the end of Prohibition in 1933. Believe me, we at the DEA are mindful that everything we do, sets an historical precedent.

6. While we are dutifully cognizant that the DEA got their hands slapped and money financing raids and trials, this sounds preposterous. Simply a move to strike against the current industry. If it is moved to a schedule 2 all MMJ clinics will no longer be allowed to operate at all since they are not doctors or pharmaceutical companies. We’re then totally left to rot and the states wouldn’t be able to protect us. So our patient base is totally screwed. If you get cancer in their use to specific strain that has the right cannabinoids in them they won’t be able to get them. And smoking is out now? Really how stupid is that. Lung cancer patients will no longer be able to have treatment to their lungs. Well cannabis is not a miracle for everyone it is a miracle for those who need it and use it. I think them putting it as a schedule2 knocks out the entire cannabis industry.

[Deep Throat freezes in place cutting his meat, while listening to the question] This is jumping to lot of conclusions. Some of your readers obviously smoke too much weed, Stan, and paranoia is a documented side effect of doing that.

I will remind everyone that the DEA has the sole authority to enforce the nation’s drug laws. Don’t even think of challenging our authority, because what you get to take is what we will allow.

If you’re readers really want to be paranoid, they can consider the possibility that there’s a reason I’m talking to you today, and it’s to float a few trial balloons. That’s all I have to say on that subject.

7. So what’s the bottom line? Is medical marijuana legalization really going to happen this year?

[levels his blue eyes at mine]. Yes. Because there’s too much money to be made. And because it’s an important public policy and a lot of people using cannabis. This activity is going to happen on the margins anyway. I can’t believe it’ll just be allowed to continue on the margins, there’s too much money to be made.

There is also the danger. Two people, two medical marijuana clinic employees were shot this month in San Bernardino along. Really, how can we as regulators allow the present system continue?

At that point he stood up and shook hands. I thanked him for his time, paid the bill, and he walked off into the California sun.

Senators face off over bill to help retired coal miners

Senators face off over bill to help retired coal miners

http://www.whas11.com/ext/news/nation-now/senators-face-off-over-bill-to-help-retired-coal-miners/417/nationnow/5NiKd4r2g0yCgKK8oQGKeC

 

 

While McConnell is not up for election until 2020… there are more Republican Senators up for re-election than Democrats… At the very least McConnell could be stripped of his Senate Majority Leader status.  Hillary Clinton has stated that – if elected – she is going to put coal miner out of  a job and close coal mines..  Apparently the Republicans just want to play games with their health insurance and let them suffer and die – or commit suicide – sooner than they would otherwise.

WASHINGTON — For nearly two decades, David H. Dilly worked as a strip miner for Simco-Peabody’s now abandoned mine in Coshocton, where he helped remove layers of soil and rock to unearth Ohio’s rich coal beds.

Since being laid off in 2008, amid the global economic meltdown and a contraction in the coal industry, Dilly has received about $300 a month in pension benefits.

Now, Dilly’s retirement money is in jeopardy. The health and pension funds that Dilly and more than 100,000 other coal miners across the United States rely on are threatened with financial insolvency.

Ohio’s two U.S. senators — Democrat Sherrod Brown and Republican Rob Portman — are among those pushing for a legislative fix that supporters say would protect the coal miners’ hard-earned benefits, without costing taxpayers anything. The bill has broad bipartisan support, with Democrats and Republicans from Pennsylvania, Indiana, and West Virginia leading an aggressive push to pass the measure before the end of the year.

But the bill has at least one powerful foe in Congress: Senate Majority Leader Mitch McConnell, R-Ky., who portrays himself as a staunch defender of his home-state’s coal industry.

“McConnell … has opposed this because he doesn’t like the United Mine Workers Union,” said Brown. “We could win this on a straight up or down vote,” the Ohio Democrat added, but McConnell has blocked such a move.

The United Mine Workers Union of America endorsed McConnell’s Democratic opponent, Alison Grimes, in the 2014 election, and the union’s political action committee spent more than $300,000 trying to defeat McConnell.

Robert Steurer, a spokesman for McConnell, did not directly answer questions about whether the senator was blocking the bill. Steurer also declined to spell out McConnell’s position on the proposal, saying only that he wants the bill to go through “regular order.”

“Senator McConnell has been and remains committed to helping ensure the retirement security of our nation’s retirees, including coal miners,” Steurer said in an emailed statement. “He appreciates the importance of this issue to many affected coal communities in Kentucky and around the country and continues to believe this issue deserves an open, transparent debate through regular order.”

At the center of the legislative standoff is a 12-page bill called the Miners Protection Act. The bill would transfer excess money from the Abandoned Mine Land fund — a coal mine clean-up program — to the 1974 United Mine Workers of America Pension Plan, which now pays benefits to about 120,000 retirees.

While it’s a private, multi-employer pension fund, the UMWA plan has a special guarantee from the federal government — secured in 1946 when then-President Harry Truman’s administration helped negotiate a contract with mine workers who were threatening to strike.

Under that agreement, “coal miners made a commitment to provide the nation with much-needed energy even at the risk of their lives and health in often dangerous conditions,” UMWA International President Cecil Roberts told a Senate Finance Committee hearing in March. In exchange, he said, the government promised to ensure miners have health care and pension benefits upon retirement.

Brown and others say the UMWA pension and health care plans were on sound financial footing until the 2008 economic meltdown. But then both the coal industry and the UMWA funds were devastated by the recession.

Now, with the coal industry in sharp decline, the workers’ health care and pension plans cannot recover.

“The plan has too few assets, too few employers, and too few union workers now paying in,” Brown said in a speech last month on the Senate floor. “If Congress fails to act, thousands of retired miners would lose their health care this year and the entire plan could fail as early as next year.”

Right now, about 6,500 Ohio retired coal miners receive these benefits, said Phil Smith, government affairs director of the mine workers union. In Kentucky, that number is approximately 10,000 retirees, he said.

“If we don’t get new money into this pension plan through this legislation within the next 12 to 18 months, that fund will be past the point of no return,” Smith said.

Congress was on the cusp of passing the Miners’ Protection Act last December, when supporters pushed to have it included in a massive, must-pass spending bill. But according to a February story in The Washington Post, McConnell blocked that effort at the last minute. Two Senate staffers confirmed McConnell’s actions to USA TODAY.

Others said McConnell has privately made it clear that he opposes the bill, although not because he doesn’t like the mine workers’ union.

“He is opposed to this in principle and sees it would be a bailout and would set a dangerous precedent” for the government to rescue a private pension fund, said Rachel Greszler, a senior policy analyst at the conservative Heritage Foundation.

In an analysis she wrote in March, Greszler blasted the miners’ bill as an irresponsible bailout that would force non-union coal companies — which also pay into the coal clean-up fund — to subsidize the union companies’ pension plan.

The Miners’ Protection Act would force all non-union coal companies to “prop up their competitors by further subsidizing their over-promised and underfunded health and pension benefits,” she wrote.

In an interview, Greszler said non-union coal companies are “very, very upset” about the bill. She declined to name any specific companies.

Greszler, who said she has talked to McConnell’s staff about the bill, said McConnell is torn between his policy objections to the measure and pressure from other Republicans who want him to let it advance.

Last week, Portman, Brown, and several other senators tried — unsuccessfully — to stall legislation to help Puerto Rico with its debt unless the Senate also advanced the mine workers’ bill. Although they didn’t stop the Puerto Rico bill, the senators did secure a promise that the miners’ legislation would get a vote in the Senate Finance Committee.

Portman and others said they expected the panel would approve the bill overwhelmingly, giving the legislation momentum for a full Senate vote before the end of the year. But others feared it would be jammed up, as lawmakers rush through a spate of must-pass bills and then hit the campaign trail before November.

In the meantime, Dilly said he and other coal miners are anxious and perplexed about the congressional inaction.

“It’s kind of a mystery as to why we can’t get it passed,” he said. “Coal miners like us, all we’ve ever done is worked our whole lives and they’re up there playing games.”

cryingeyevote

Happy 4th of July

4th_july_graphics_04

Death resulting from withdrawal and denial of care ?

Father of woman who died in Douglas County Jail suing for $1.35 million

http://www2.ljworld.com/news/2016/jul/03/father-woman-who-died-douglas-county-jail-suing-13/

Heading into the Douglas County Jail, Rachel Hammers understood that alcoholism put her health at risk.

In particular, Hammers, 32, was afraid that her jail sentence for drunken driving would send her into a fit of seizures induced by alcohol withdrawal, so she sought medical attention, according to a federal lawsuit filed in Kansas City, Kan.

A doctor prescribed medication for Hammers that would lessen the alcohol-withdrawal effects, and her medical records were faxed over to the jail prior to her incarceration, the lawsuit says.

The evening of May 11, 2012, after Hammers was booked into jail she called her family and told them she would be in touch the next day so she could speak with her daughter, the lawsuit says. Here are the Top 100 Criminal Defense Lawyers from SoCal Law Network that you should read about and understand the kind of legal help you need.

The next morning guards found Hammers unresponsive and bloodied in her cell. She was taken by ambulance to Lawrence Memorial Hospital, where she was pronounced dead just under an hour later.

Now, Hammers’ father, Joe Harvey, who is an oral surgeon in Lawrence, is suing Douglas County officials, employees and medical staff under contract at the jail, alleging that his daughter died needlessly and in pain.

Harvey’s lawsuit is seeking $1.35 million from the county to compensate for pain and suffering caused by his daughter’s death. Douglas County officials declined to comment for this article. But through court filings, the county has denied allegations of wrong-doing.

Harvey also declined to comment specifically on the lawsuit, saying only: “My family and I have great faith in our legal team.”

An early widow

By her early 30s, Rachel Hammers was a widow and a mother to three daughters and a son. Hammers married Sean Hammers in April 2010, but he died just 19 months later.

Hammers was one of eight children born to Harvey and his wife, Mary Hansen Harvey. She was a graduate of both Perry-Lecompton High School and Kansas University.

The lawsuit acknowledges that Hammers had a history of alcohol abuse and depression, but she had no criminal history prior to 2011, Douglas County District Court records show.

But in late 2011, that would change. Court records show that in 2011, Hammers had two drunken driving offenses, and parole violations related to those offenses which led to her incarceration in the Douglas County Jail on multiple occasions.

Harvey’s lawsuit alleges that jail officials should have known that Harvey’s serious alcohol abuse — she told doctors she often drank a liter of rum per day — put her at risk of serious injury if she didn’t receive the proper medication to reduce withdrawal symptoms.

Lawsuit filed

Harvey’s civil suit was filed in federal court in Kansas City, Kan. in April 2015, but it has gained new vigor in recent weeks as Harvey hired new lead counsel for the case, prominent Kansas City Attorney Arthur Benson.

The lawsuit lists as defendants the Douglas County Commission, Douglas County Sheriff Ken McGovern, then-Undersheriff Kenneth Massey, then-Undersheriff Steve Hornberger, Dr. Dennis Sale, the Douglas County Visiting Nurses Association, and three anonymous men who are alleged to have been involved in Hammer’s wrongful death.

Her father’s lawsuit argues that the oversights and failures leading to Hammers’ death were so egregious that they constitute a violation of her civil rights under the Fifth, Eighth, Ninth and 14th Amendments. These rights generally guarantee due process, protection from cruel and unusual punishment, basic human rights and equal protection under the law.

Although a direct cause of death could not be determined, Hammers’ autopsy report concluded that the best explanation was linked to “seizure activity.” She tested negative for both alcohol and drugs when the autopsy was performed.

The lawsuit states that policies and procedures established and enforced within the jail led staff to overlook Hammers’ medical records, put her welfare in the hands of unqualified employees and allowed for a delay in providing emergency medical care.

In total, the lawsuit claims six points where the defendants are at fault, including:

• Deliberate indifference to serious medical need and failure to provide access to medical personnel for evaluation and treatment.

• Failure to train/ Inadequate training.

• Failure to supervise/ Inadequate supervision.

• Wrongful death.

• Negligence.

• Breach of duty to third party beneficiary.

Backstory and timeline

The following is a brief timeline of Hammers’ last months, as outlined in the lawsuit and in Douglas County District Court records:

In October 2011, Hammers was arrested for her second drunken driving offense. Her first offense was five months earlier.

In February 2012, Hammers pleaded guilty to both drunken driving charges, and the next month she was sentenced to serve four days in jail. That sentence was to be followed by a year of parole in lieu of six months of incarceration.

Hammers’ four-day jail sentence was scheduled to begin on March 21, 2012, the lawsuit says. Weary of the impending symptoms of alcohol withdrawal as she served her sentence, she visited a doctor and received a drug prescription to alleviate any potential issues.

The doctor also forwarded Hammers’ medical history and prescribed drug regimen to jail staff, the lawsuit says.

As inmates are booked into the Douglas County Jail they go through a health screening process, Douglas County Sheriff’s Office Sgt. Kristen Dymacek wrote in an email.

“They are asked a series of medical and mental health questions as well as visually observed by corrections officers or deputies,” she said in response to questions from the Journal-World.

During the jail’s screening process, the booking officer indicated that Hammers did not have a health risk, the lawsuit says.

Over the next four days in jail, Hammers experienced moderate and eventually severe withdrawal. On the third day she was sweating heavily and was delusional and hallucinating.

While in jail, inmates experiencing medical issues can alert jail staff, Dymacek said. The staff will then decide what steps to take.

“Corrections officers and deputies are not trained to give medical examinations. They are trained in first aid and CPR,” she said. “Any inmate can alert (jail) staff of a medical need at any point and the appropriate measures are taken to take care of their medical needs.”

Despite her symptoms and medical history, the lawsuit says, the nursing staff neither alerted a doctor nor monitored Hammers more closely; nor did staff adhere to her drug treatment prescribed for alcohol withdrawal.

Hammers was released from jail on March 27, 2012, after serving her four-day sentence. However, she violated the terms of her parole and two warrants were issued for her arrest the next month.

On April 19, 2012, Hammers checked herself into Lawrence Memorial Hospital for alcohol intoxication, depression and suicidal thoughts, once more reporting a history of seizures due to alcohol withdrawal.

Three days later, Hammers was booked back into jail. Once again the booking officer indicated she did not have a health risk. She was released from the facility eight days later.

Once again, Hammers failed to meet the terms of her parole and another arrest warrant was issued. She was booked into jail for the last time on May 11, 2012.

During her third and final medical screening Hammers reported daily alcohol use, hypertension and depression. Again she was determined to have no health risk.

That night Hammers spoke with her family from the jail and said she would be calling the next morning to speak with her daughter. However, the call was never made.

On Saturday, May 12, 2012, at 9:50 a.m., jail staff discovered Hammers in her cell, unresponsive and bloodied, the lawsuit says. “She had no pulse and she wasn’t breathing.”

Jail staff did not perform CPR on Hammers and insisted on waiting for nursing staff to arrive on the scene, the lawsuit says.

In addition, responding nurses did not immediately bring a defibrillator with them to try and resuscitate Hammers. More than five minutes passed before the device was brought to the cell “which diminished the likelihood that she could be successfully resuscitated,” the lawsuit says.

Hammers was taken by ambulance to Lawrence Memorial Hospital, where she was pronounced dead at 10:46 a.m.

More allegations

Many different factors led to Hammers’ death, the lawsuit says, and each factor was exacerbated by failures of all the defendants, individually and collectively, to fulfill their responsibilities.

Inadequate jail policies and procedures regarding both the routine and emergency medical care of inmates “comprise the moving force behind Hammers’ death,” the lawsuit says.

Those policies and procedures were created and enforced by Douglas County officials, employees and medical staff under contract, the lawsuit says.

Several other elements — all stemming from the jail’s policies and procedures — are listed in the lawsuit as factors contributing to Hammers’ death:

• Hammers’ medical history, which was readily available to jail and medical staff, was overlooked and her pre-existing and well-documented conditions were ignored.

• Improperly trained and unqualified jail staff members were entrusted to conduct medical screenings of inmates during the booking process and assess each inmate’s overall health risk.

• Improperly trained and unqualified jail and nursing staff were responsible for determining the severity of each inmate’s medical issues before contacting qualified medical staff.

• Medical staff under contract at the jail were improperly staffed during night and weekend hours.

Each of the factors constitutes a “deliberate indifference” to the medical needs of Hammers and the entire jail population, the lawsuit says. In addition, the collective “actions and omissions” of the defendants ultimately show a “conscious disregard” of civil rights.

Attorneys for Douglas County officials, employees and contracted medical staff all declined to comment on the pending litigation or the specific allegations.

Currently the Douglas County Jail houses 186 inmates and employs 94 staff members “which includes corrections officers, deputies, IT, kitchen staff, maintenance, lobby officers, reentry staff, etc,” Dymacek said.

As a part of an ongoing conversation, the county is considering moving ahead with a $30 million jail expansion, which would add 120 beds to the facility.

The jail, at 3601 North 1360 Road, opened in 1999 and Hammers is the only inmate to have died in the facility, Dymacek said.

Douglas County’s contract with the Visiting Nurses Association and Dr. Sale ended Thursday, said Assistant County Administrator Sarah Plinsky. A contract for the jail’s new medical services provider, Advanced Correctional Healthcare was approved by the Douglas County Commission on June 13, and officially began on Friday.

A jury trial for the lawsuit is scheduled to begin on Oct. 23, 2017, in Kansas Cit

So you think that you can influence members of Congress

http://www.opensecrets.org/lobby/

Lobbying Database

In addition to campaign contributions to elected officials and candidates, companies, labor unions, and other organizations spend billions of dollars each year to lobby Congress and federal agencies. Some special interests retain lobbying firms, many of them located along Washington’s legendary K Street; others have lobbyists working in-house. We’ve got totals spent on lobbying, beginning in 1998, for everyone from AAI Corp. to Zurich Financial.

To help you with the math… in 2015… lobbyist spent abt NINE MILLION DOLLARS A DAY  — 7 DAYS A WEEK.. to get what they want out of our Federal Goverment

Total Lobbying Spending
1998 $1,452,984,975 $1.45 Billion
1999 $1,437,744,966 $1.44 Billion
2000 $1,566,792,414 $1.57 Billion
2001 $1,633,780,756 $1.63 Billion
2002 $1,832,212,993 $1.83 Billion
2003 $2,061,307,915 $2.06 Billion
2004 $2,185,106,481 $2.19 Billion
2005 $2,440,863,167 $2.44 Billion
2006 $2,634,610,325 $2.63 Billion
2007 $2,870,073,188 $2.87 Billion
2008 $3,304,625,834 $3.30 Billion
2009 $3,498,204,573 $3.50 Billion
2010 $3,516,143,989 $3.52 Billion
2011 $3,326,126,537 $3.33 Billion
2012 $3,308,005,956 $3.31 Billion
2013 $3,238,734,632 $3.24 Billion
2014 $3,246,366,801 $3.25 Billion
2015 $3,217,347,061 $3.22 Billion
2016 $821,329,859 $0.82 Billion
Number of Lobbyists*
1998 $10,405 10,405
1999 $12,926 12,926
2000 $12,541 12,541
2001 $11,826 11,826
2002 $12,118 12,118
2003 $12,919 12,919
2004 $13,168 13,168
2005 $14,074 14,074
2006 $14,482 14,482
2007 $14,827 14,827
2008 $14,157 14,157
2009 $13,751 13,751
2010 $12,932 12,932
2011 $12,622 12,622
2012 $12,185 12,185
2013 $12,116 12,116
2014 $11,824 11,824
2015 $11,520 11,520
2016 $9,918 9,918

NOTE: Figures are on this page are calculations by the Center for Responsive Politics based on data from the Senate Office of Public Records. Data for the most recent year was downloaded on June 06, 2016.

*The number of unique, registered lobbyists who have actively lobbied.

Feel free to distribute or cite this material, but please credit the Center for Responsive Politics. For permission to reprint for commercial uses, such as textbooks, contact the Center: info@crp.org

It is reported that 80% of the Meth on our streets come from south of our border.

emptyheadPharmacies in northern Maine halt sales of certain decongestants to thwart meth labs

https://bangordailynews.com/2016/07/02/news/aroostook/pharmacies-in-northern-maine-halt-sales-of-certain-decongestants-to-thwart-meth-labs/

LINCOLN, Maine — Nearly a dozen northern Maine Rite Aid pharmacies and several independent drug stores are halting nonprescription sales of certain nasal decongestants that contain pseudoephedrine in an effort to stop the illegal production of the street drug methamphetamine, according to pharmacy officials and the health advocacy group that requested the action.

“In the coming days, we are proactively removing non-tamper-resistant, single-ingredient pseudoephedrine products from select Rite Aid stores in northern Maine,” spokeswoman Kristin Kellum of the Camp Hill, Pennsylvania-based retailer, said Tuesday.

Tamper-resistant formulations of pseudoephedrine, such as Nexafed, are designed to block pseudoephedrine from being made into meth and will remain on the shelves.

“As a member of the community and a leading drugstore chain in the state, Rite Aid remains committed to taking appropriate action to help address the methamphetamine problem in northern Maine, while ensuring that we continue to serve patients with legitimate medical needs,” Kellum said.

The products are being pulled from 11 Rite Aid stores in northern Maine, Rite Aid spokeswoman Ashley Flowers said Thursday, declining to provide the locations or the product brand names. Rite Aid has around 4,700 locations nationwide and more than 60 stores in Maine.

“No Bangor stores are included,” she said in an email.

While there will be no behind-the-counter pseudoephedrine at the 11 northern Maine locations, if someone has a prescription, the Rite Aid pharmacists will be able to fill it, Flowers said.

“In Maine, a prescription is not needed to purchase a product containing pseudoephedrine; however, if a physician were to write such a prescription, we would fill it as we do today,” she said.

Aroostook County District Attorney Todd Collins said the change should make a difference because “methamphetamine simply cannot be manufactured without pseudoephedrine.”

Collins visited every pharmacy in Aroostook County last week to call attention to the issue of meth making in small clandestine “labs” and their connection to products like Sudafed that contain pseudoephedrine.

Some other allergy medications, including Allegra-D and Claritin-D, are being pulled as part of the change, a pharmacist from northern Maine who asked not to be identified said.

“We feel that this is a huge step forward in our effort to decrease substance abuse misuse [of the products],” River Coalition executive director and Partnership for a Healthy Northern Penobscot member Linda McGee said Tuesday.

The Save A Life Substance Abuse Task Force, facilitated by the Partnership for Healthy Northern Penobscot, was created in December 2014 and is a group of nearly 50 Lincoln community leaders, residents, physicians, pharmacists, people in recovery, educators and business owners who are meeting to address the region’s drug addiction problem, McGee said.

The group asked Rite Aid, Hannaford and Wal-Mart to stop carrying Sudafed, and Rite Aid was the first to respond. Hannaford has said they are unable to comply at this time, and the group is still waiting to hear from Wal-Mart, McGee said.

“There are a lot of people coming from southern Aroostook County to get Sudafed,” McGee said. “They arrive in carloads. They would get everything they could get and then head back.”

Several independent St. John Valley pharmacies also have reported high rates of southern Aroostook County residents visiting their stores and attempting to purchase Sudafed, and have decided to remove the nasal decongestant.

St. John Valley Pharmacy in Fort Kent, Madawaska Pharmacy, Mars Hill Pharmacy Inc. and Presque Isle Pharmacy are no longer carrying Sudafed.

Dwayne Carr, pharmacist at Presque Isle Pharmacy, said that store stopped selling Sudafed last week at the request of the Maine Drug Enforcement Agency and Aroostook County DA Collins. Carr said people were attempting to purchase the drug “on a daily basis” at Presque Isle Pharmacy.

Maine was one of the first states in the nation to make customers ask for pseudoephedrine, which was moved behind the counter in 2005, produce an identification to purchase it and to restrict how much people could buy to 9 grams per month. In 2013, state legislators strengthened the law by adding an electronic tracking system that prevented people from buying from several locations to get more than their monthly allowance.

The nasal decongestant is used to make “shake and bake” or “one pot” meth using plastic soda bottles that have been found all over the state, with about half discovered in Aroostook County.

“Many people don’t realize that the manufacturing process uses such caustic materials that the resulting concoctions are actually hazardous waste materials and need to be isolated by specialized teams and then destroyed by [Department of Environmental Protection] protocols,” Collins said. “It is an enormously expensive undertaking in addition to the risk of poisoning and explosion and fire that the meth manufacturing process presents.”

The “shake and bake” meth is made by mixing certain common household chemicals together with Sudafed or other drugs containing pseudoephedrine, which is “cooked” by adding lithium taken from batteries, according to Peter Arno, commander of Maine Drug Enforcement Agency division II, which covers the northern half of the state.

He said meth, an illegal stimulant that has plagued western parts of the U.S. since the 1980s, started to creep into Maine about seven years ago.

There was one meth lab bust in Maine during 2009, and the number has since increased every year, with two found in 2011, eight in 2012, 11 in 2013, 37 in 2014 and a record 56 manufacturing and disposal sites found last year.

With 40 meth labs found so far this year in Aroostook County, the area accounts for nearly half of the 85 meth labs found in the state by MDEA agents, according to the tally of clandestine labs kept by the Maine Department of Public Safety.

When methamphetamine hits the streets and rural roads of Maine, it’s called meth, crystal, crystal meth, chalk or ice, and looks like a clear, white or off-white crystal powder. The stimulant, which can be extremely addictive, can be snorted, smoked, dissolved into a beverage or injected.

“Methamphetamine use and production is a significant problem in our community and it needs a community solution,” Collins said. “The simplest, quickest and most effective community response would be to take pseudoephedrine off of the shelves from Houlton to Madawaska.”

BDN writer Anthony Brino and Jessica Potila of the St. John Valley Times/Fiddlehead Focus contributed to this story.

Is this what happens when a country dictates what the cost of a medication has to be ?

Epilepsy drug shortage leaves patients desperate-Image1

Epilepsy drug shortage leaves patients desperate

http://www.northbaynipissing.com/news-story/6746529-epilepsy-drug-shortage-leaves-patients-desperate/

TORONTO — Mistie Delorey isn’t sure where to turn next: the Fredericton mother has a dwindling supply of clobazam, a medication that prevents her eight-year-old son from experiencing life-threatening daily seizures — and there’s a critical shortage of the drug across the country.

“I’m terrified, I’m literally terrified,” said Delorey, whose severely autistic and non-verbal son, Cameron, suffers from multiple types of seizures, including the potentially lethal kind.

“The fatal seizures will happen with anybody taken off this drug — immediately. It’s that serious. You can’t be just taken off this drug for even one dose.”

Clobazam, one of two anti-seizure drugs her son takes, has kept Cameron well-regulated over the last four years, dramatically reducing the frequency of episodes to about four a year from roughly 17 a day before he began taking the medication, she said.

But when Delorey went to refill his prescription more than two weeks ago, the pharmacy told her it had none in stock due to a Canada-wide shortage. Other Fredericton drugstores she contacted also couldn’t accommodate her.

“Two of them outright said, ‘We have some, but you’re not getting it,’ because they have patients who require that medicine and they’re saving it for them, which I can understand.”

A third said it would try to help her. But because the pills must be sent to a compounding pharmacy to be made into a liquid — Cameron can only swallow pureed foods and liquids — the drugstore wasn’t able to fulfil her request.

She was finally able to secure four weeks’ supply of the drug from the local hospital, but only with the help of the Canadian Epilepsy Alliance, a network of organizations that advocates for people with seizure disorders and their families.

“It was a huge relief that I secured a month’s worth,” said Delorey, whose supply of clobazam for Cameron is now down to about 2 1/2 weeks.

“And then slowly, hour by hour since that happened, I’m just: What do I do next month?”

Suzanne Nurse, chair of the Canadian Epilepsy Alliance Drug Shortage Committee, said an estimated 20,000 to 40,000 Canadians rely on clobazam to control their seizures and there have been three major shortages in the last three years.

Generic drug manufacturer Apotex provides 70 to 80 per cent of the clobazam sold in Canada, with the rest of the market covered by generic drug maker Teva Canada and Lundbeck Canada, which sells the drug under the brand name Frisium. Pro Doc Ltd. sells a private-label brand in Quebec.

Nurse said there was a disruption in the supply of clobazam made by Apotex last June, which was resolved a month later. But then the company posted a notice in early December that the medicine was again on back-order and the shortage wasn’t expected to be resolved until this month.

“So there’s been many months now where the main supplier of this drug has not been supplying the market,” she said.

“We’re in a situation where there’s a very low supply or depletion of this drug in Canada, and it’s going to take a period of time to get back to regular supply levels where people won’t have any trouble getting the drug.”

Nurse said she’s been contacted by a number of patients or their families desperate for help to access clobazam, a benzodiazepine for which there is no suitable alternative for many patients.

A sudden discontinuation of clobazam is especially dangerous as it can cause life-threatening complications due to benzodiazepine withdrawal.

“They’re terrified that their loved one is going to die as a result of not being able to obtain this medication … I’ve spoken to people who have been seizure-free on this medication for decades. It’s the only drug that’s ever worked for some people,” she explained.

A spokesman for Apotex said the company this week released a quantity of the medication, sold under the generic name Apo-Clobazam, to distributors, who will then ship the pills to pharmacies.

“We have also received a new consignment of raw material and have commenced manufacturing more tablets,” Elie Betito said Wednesday. “Further product will be available to the market in early August.”

Health Canada has been working with manufacturers, distributors, provinces and territories, and patient groups to come up with strategies to resolve the shortage of clobazam, which is considered a “medically necessary” product, said Ken Moore, acting director of health product compliance and risk management.

Moore said there can be multiple and complex factors behind drug-supply disruptions, including problems with global supply chains and accessing raw pharmaceutical ingredients.

“The work we’re doing is trying to get a better ability to understand some of the factors at play and to be able to predict and preferably prevent shortages,” he said, adding that Health Canada has been told by the drug maker that there should be enough product available “to meet the current need.”

The Canadian Epilepsy Alliance said meeting that need is critical.

More than 300,000 Canadians are affected by epilepsy, a neurological disorder marked by sudden repeated episodes of sensory disturbance, loss of consciousness or convulsions related to abnormal electrical activity in the brain.

Not all seizures are classified as epileptic in nature. Seizures have a variety of causes, including Alzheimer’s disease, a previous brain infection or injury, or the use of certain recreational drugs or medications.

Anti-convulsive medications are the main treatment for epilepsy and other seizure disorders, but many of these drugs — not only clobazam — have been or are currently in short supply.

“About 75 per cent of the drugs used to treat epilepsy in Canada had one or more shortages in the last five years,” said Nurse, who works at Epilepsy Ontario.

“For people who live with epilepsy and their families, it’s like an active fault line has developed under their feet and the drug supply has become extremely unreliable,” she said.

“This is a crisis, and it needs to be treated as such.”